• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cartesian Therapeutics, Inc. - Common Stock (NQ: RNAC )

    22.22 -1.90 (-7.88%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 69,271
    Open 23.93
    Bid (Size) 22.40 (1)
    Ask (Size) 24.30 (2)
    Prev. Close 24.12
    Today's Range 22.11 - 24.43
    52wk Range 11.66 - 42.60
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
    Amgen tested its drug, Uplizna, in generalized myasthenia gravis, a market where Argenx's Vyvgart leads. 
    Via Investor's Business Daily
    RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024
    RNAC stock results show that Cartesian Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +13.04%
    +13.04%
    1 Month
    +69.36%
    +69.36%
    3 Month
    +32.42%
    +32.42%
    6 Month
    +58.83%
    +58.83%
    1 Year
    -30.78%
    -30.78%

    More News

    Read More
    Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs
    Via Investor's Business Daily
    Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M
    Via Benzinga
    RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Cartesian Therapeutics Announces New Employment Inducement Grants
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
    Via Benzinga
    Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    Cartesian Therapeutics Announces New Employment Inducement Grants
    From Cartesian Therapeutics
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    SolarEdge Layoffs 2024: What to Know About the Latest SEDG Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.